Articles By Nushin Rashidian
FDA Commissioner Robert Califf Says He is “Committed” to Finding a “Path” for CBD
The U.S. Food and Drug Administration has been working for years on rules for products containing cannabis-derived compounds like CBD. But nothing has yet materialized.
New York Awards Another 58 Adult Use Cannabis Cultivation Licenses, Bringing Total to 146
At Thursday’s Cannabis Control Board meeting, the Dormitory Authority also gave an overview of its current RFPs on cannabis.
Rhode Island’s Adult Use Cannabis Compromise Moves Forward
A revised bill released this week is the product of negotiations among lawmakers and the governor, who released his own adult use proposal in his budget.
From Sheet Metal to Beef, Cannabis Draws Diverse Lobbying Interests
Each year, the list of entities lobbying on cannabis grows longer. And, more diverse.
Kellogg, PepsiCo, General Mills Call on Congress to Act on Copycat Cannabis Edibles
In a letter led by the Consumer Brands Association, some of the biggest brands in the world urged action on THC edibles that resemble their own products.
Here’s How Much Cannabis Entities Spent Lobbying So Far in 2022
Last year, spending rebounded from a 2020 drop. But it’s remained broadly unchanged since then – much like the movement on cannabis reform in Congress.
New York’s Cannabis Industry Will Get Tax Relief Through the Budget
With the overdue budget agreement, passed on Saturday, the state became one of a handful to allow cannabis businesses to write off the same expenses as other businesses.
Federal Workplace Drug Testing Guidelines Will Be Tightened
The Health and Human Services Department wants to clarify its language on how impairment, including for cannabis, is measured in federal employees.
Cannabis Research Bills Advance in Congress
The House and Senate have both passed proposals to expand cannabis research – with key differences – just as they did in late 2020. Will one land on President Joe Biden's desk?
